L. Monereau

发表

Development of BET Inhibitors as Potential Treatments for Cancer: Optimization of Pharmacokinetic Properties

M. D. Hill, Derek J. Norris, J. Tokarski, 2022, ACS Medicinal Chemistry Letters.

Development of BET inhibitors as potential treatments for cancer: A search for structural diversity.

M. D. Hill, J. Tokarski, S. Sheriff, 2021, Bioorganic & medicinal chemistry letters.

A High-Throughput BRET Cellular Target Engagement Assay Links Biochemical to Cellular Activity for Bruton’s Tyrosine Kinase

B. Arey, C. Chaudhry, A. Tebben, 2019, SLAS discovery : advancing life sciences R & D.

Discovery of Non-Nucleotide Small-Molecule STING Agonists via Chemotype Hybridization.

Alan S. Futran, Vijay T. Ahuja, Shana L. Posy, 2022, Journal of medicinal chemistry.